Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells

EZH2 (enhancer of zeste homolog 2) is the catalytic subunit of PRC2 (polycomb repressive complex 2), which mediates histone methyltransferase activity and functions as transcriptional repressor involved in gene silencing. EZH2 is involved in malignant transformation and biological aggressiveness of...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Kikuchi, Junko, Takashina, Taichi, Kinoshita, Ichiro, Kikuchi, Eiki, Shimizu, Yasushi, Sakakibara-Konishi, Jun, Oizumi, Satoshi, Marquez, Victor E., Nishimura, Masaharu, Dosaka-Akita, Hirotoshi
Format: Artigo
Jezik:Inglês
Izdano: 2012
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3472089/
https://ncbi.nlm.nih.gov/pubmed/22925699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2012.08.003
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items